FNY Investment Advisers, LLC

Position in IMDX — Insight Molecular Diagnostics Inc.

CIK 1742998 NEW YORK, NY

Position in IMDX

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,077,109

+$265,569 QoQ

Shares Held

182,561

-26.2% QoQ

Ownership

0.565%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

of 2 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $1,326,321 across 4 Diagnostics & Research names. IMDX ranks #1 (81.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMDX	Insight Molecular Diagnostics Inc. This page	182,561	$1,077,109
2	ILMN	Illumina, Inc.	650	$114,289
3	TMO	Thermo Fisher Scientific Inc.	150	$75,204
4	NTRA	Natera, Inc.	220	$59,719

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,077,109	182,561	-26.2%	Shares	Sole	2026-07-08
2026-03-31	$811,540	247,421	+509.7%	Shares	Sole	2026-04-15
2025-12-31	$304,380	40,584	-23.5%	Shares	Sole	2026-01-16
2025-09-30	$176,215	53,077	+115.3%	Shares	Sole	2025-12-15
2025-06-30	$74,443	24,650	-37.1%	Shares	Sole	2025-07-30
2025-03-31	$119,866	39,172	-20.7%	Shares	Sole	2025-04-17
2024-12-31	$117,517	49,377	+15.1%	Shares	Sole	2025-01-13
2024-09-30	$122,253	42,896	+81.3%	Shares	Sole	2024-10-18
2024-06-30	$69,779	23,654	—	Shares	Sole	2024-08-05
No filing history on record for this holder in this stock.